Reviewing Medartis (OTCMKTS:MDRSF) and Inari Medical (NASDAQ:NARI)

Medartis (OTCMKTS:MDRSF) and Inari Medical (NASDAQ:NARI) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Earnings and Valuation

This table compares Medartis and Inari Medical”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medartis	N/A	N/A	N/A	N/A	N/A
Inari Medical	$493.63 million	5.19	-$1.64 million	($0.99)	-44.40

Medartis has higher earnings, but lower revenue than Inari Medical.

Institutional and Insider Ownership

91.0% of Inari Medical shares are owned by institutional investors. 10.6% of Inari Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and target prices for Medartis and Inari Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medartis	0	0	0	0	N/A
Inari Medical	0	6	5	0	2.45

Inari Medical has a consensus target price of $57.44, suggesting a potential upside of 30.67%. Given Inari Medical’s higher probable upside, analysts clearly believe Inari Medical is more favorable than Medartis.

Profitability

This table compares Medartis and Inari Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medartis	N/A	N/A	N/A
Inari Medical	-10.42%	-7.51%	-5.25%

Summary

Inari Medical beats Medartis on 5 of the 8 factors compared between the two stocks.

About Medartis

Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. It serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. The company was founded in 1997 and is headquartered in Basel, Switzerland.

About Inari Medical

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.